Duncan Gallagher
CIK: 0001780880
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Health Catalyst, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 17, 2026HCAT
Health Catalyst, Inc.
Award(A)Direct7.6K shares- - Dec 1, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct6.2K shares- - Sep 1, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct5K shares- - Jul 9, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct36.2K shares- - Jun 1, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct4.1K shares- - Mar 1, 2025HCAT
Health Catalyst, Inc.
Award(A)Direct3K shares- - Dec 30, 2024HCAT
Health Catalyst, Inc.
Sale(S)Direct4.5K shares at avg. $6.93$31K - Dec 23, 2024HCAT
Health Catalyst, Inc.
Sale(S)Direct4.5K shares at avg. $6.98$31K - Dec 1, 2024HCAT
Health Catalyst, Inc.
Award(A)Direct2K shares- - Sep 1, 2024HCAT
Health Catalyst, Inc.
Award(A)Direct2.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 17, 2026 | HCAT Health Catalyst, Inc. | Award(A) | 7,562 | - | $0 | Direct |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 6,209 | - | - | Direct |
| Sep 1, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 4,970 | - | - | Direct |
| Jul 9, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 36,231 | - | - | Direct |
| Jun 1, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 4,080 | - | - | Direct |
| Mar 1, 2025 | HCAT Health Catalyst, Inc. | Award(A) | 3,033 | - | - | Direct |
| Dec 30, 2024 | HCAT Health Catalyst, Inc. | Sale(S) | 4,500 | $6.93 | $31,184 | Direct |
| Dec 23, 2024 | HCAT Health Catalyst, Inc. | Sale(S) | 4,500 | $6.98 | $31,415 | Direct |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | Award(A) | 2,001 | - | $0 | Direct |
| Sep 1, 2024 | HCAT Health Catalyst, Inc. | Award(A) | 2,414 | - | $0 | Direct |
1-10 of 10 transactions
About Gallagher Duncan
Gallagher Duncan (SEC CIK 0001780880) files insider reports with the SEC as Director of Health Catalyst, Inc. (HCAT).
Signal8 holds 10 ownership filings by Gallagher Duncan, all Form 4s, filed between Sep 10, 2024 and Feb 19, 2026. Those filings report 10 transactions, from Sep 1, 2024 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gallagher Duncan's filings is in SOUTH JORDAN, UT.
Recent filings by Gallagher Duncan
- Feb 17, 2026: Grant or award of HCAT shares (Form 4, code A).
- Dec 1, 2025: Grant or award of HCAT shares (Form 4, code A).
- Sep 1, 2025: Grant or award of HCAT shares (Form 4, code A).
- Jul 9, 2025: Grant or award of HCAT shares (Form 4, code A).
- Jun 1, 2025: Grant or award of HCAT shares (Form 4, code A).
Other insiders filing for Health Catalyst, Inc. (HCAT)
- Reller Tami, Director
- Kohl Simeon, Chief Executive Officer
- Albert Benjamin, CEO
- Larson-Green Julie, Director
- Alger Jason, Chief Financial Officer
- Landry Benjamin, General Counsel